The decision was published on September 26 in DOU (Diário Oficial da União), considering the dosage of 5g a day
Gelita’s bioactive collagen peptide Fortigel has been authorised by Brazil’s National Health Agency (Anvisa). The product’s label can now mention the benefits for joint health of food supplements
The authorisation came with the wording “may contribute to the maintenance of joint health” on the labels of food supplements formulated with the ingredient patented by Gelita, a leader in the manufacture and supply of gelatin and collagen.
“Fortigel is the first type of collagen to receive this joint approval. Supported by several studies carried out by the international scientific community, proving its effectiveness, and confirming the premise that not all collagens are the same,” said Léia Tomaz Pipulini, Gelita’s Head of the Nutrition & Health Ingredients.
Pipulini continued: “It is gratifying that the functional effectiveness of our solution dedicated to joint health received this important approval from the regulatory agency in the Brazilian market.”
This new recognition adds to Anvisa's authorisation, obtained at the end of 2020, for the bioactive collagen peptides Verisol for maintenance of skin health. These collagen peptides from GELITA are the only collagen to have such endorsement in the Brazilian market and have other approved claims in Canada and Japan.
Independent clinical studies have shown that the daily intake of 5 grams of the bioactive collagen peptides with an average molecular mass of 3kDa helps in the reconstruction of the extracellular matrix of the joint cartilage
Data from the CDC indicates that, today, one in four people in the world suffers from joint problems. In the United States, for example, 58.5 million adults have arthritis, an inflammatory condition in the bone joints that causes pain, reduces mobility, and compromises dexterity in a number of daily activities.
Collagen can contribute to joint health as it represents 70% of the composition of cartilage tissue, which has the function of cushioning body weight at the junctions between the bones of the body – and which can be weakened and can be damaged and lead to pathologies such as osteoarthritis.
According to Georgia Alvares de Castro MSc. Ph.D., Scientific Consultant at GELITA: “Independent clinical studies have shown that the daily intake of 5 grams of the bioactive collagen peptides with an average molecular mass of 3kDa helps in the reconstruction of the extracellular matrix of the joint cartilage.”
Alvares continued: “Due to the physiological and metabolic action on cartilage tissue, it is possible to observe a reduction in the pain scale as a clinical outcome.”
Fortigel comprises bioactive collagen peptides with an average molecular weight of 3kDa that works optimally in joint health, maximising the desired interaction with the cells involved in cartilage metabolism.